摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-溴-2-甲基异氰酸苯酯 | 1591-98-6

中文名称
4-溴-2-甲基异氰酸苯酯
中文别名
4-溴-2-甲基苯基异氰酸酯
英文名称
4-bromo-1-isocyanato-2-methylbenzene
英文别名
2-methyl-4-bromophenyl isocyanate;4-bromo-2-methylphenyl isocyanate
4-溴-2-甲基异氰酸苯酯化学式
CAS
1591-98-6
化学式
C8H6BrNO
mdl
——
分子量
212.046
InChiKey
NXAYRHQYINQHRF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    47-50 °C(lit.)
  • 沸点:
    78 °C(Press: 1 Torr)
  • 密度:
    1.44±0.1 g/cm3(Predicted)
  • 闪点:
    >230 °F
  • 稳定性/保质期:

    在常温常压下保持稳定,应避免与强氧化剂、水分、酒精和胺类物质接触。

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    29.4
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险等级:
    6.1
  • 危险品标志:
    Xn
  • 危险类别码:
    R42,R36/37/38,R23/25
  • 危险品运输编号:
    2811
  • WGK Germany:
    3
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 安全说明:
    S26,S36
  • 危险性防范说明:
    P261,P280,P305+P351+P338,P342+P311
  • 危险性描述:
    H302,H312,H315,H319,H332,H334,H335
  • 储存条件:
    存储在干燥的惰性气体中,并保持容器密封。将其存放在阴凉、干燥处。

SDS

SDS:7cbd61195113a9c28d91d4f3cdb271ae
查看
Name: 4-Bromo-2-methylphenyl isocyanate Material Safety Data Sheet
Synonym:
CAS: 1591-98-6
Section 1 - Chemical Product MSDS Name:4-Bromo-2-methylphenyl isocyanate Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
1591-98-6 4-Bromo-2-methylphenyl isocyanate unlisted
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.Moisture sensitive.
Potential Health Effects
Eye:
Causes eye irritation. Lachrymator (substance which increases the flow of tears).
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. Use only in a chemical fume hood.
Storage:
Keep refrigerated. (Store below 4C/39F.) Store in a tightly closed container. Store in a dry area. Store under nitrogen.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1591-98-6: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 47 - 49 deg C
Autoignition Temperature: Not available.
Flash Point: > 110 deg C (> 230.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H6BrNO
Molecular Weight: 212

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, exposure to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents, bases, alcohols, amines.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, carbon monoxide, carbon dioxide, hydrogen bromide, acrid smoke and fumes, bromine.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1591-98-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Bromo-2-methylphenyl isocyanate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 1591-98-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 1591-98-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1591-98-6 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-溴-2-甲基异氰酸苯酯 在 palladium bis[bis(diphenylphosphino)ferrocene] dichloride potassium carbonate 作用下, 以 1,4-二氧六环二氯甲烷 为溶剂, 反应 6.5h, 生成 5-{[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl}-4-(4'-fluoro-3-methyl-4-biphenylyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
    参考文献:
    名称:
    [EN] TRIAZOLONES AS FATTY ACID SYNTHASE INHIBITORS
    [FR] TRIAZOLONES UTILISÉES COMME INHIBITEURS D'ACIDES GRAS SYNTHASE
    摘要:
    这项发明涉及三唑酮衍生物在调节脂肪酸合成酶(FAS)的活性或功能,特别是抑制其活性或功能方面的用途。适当地,本发明涉及三唑酮在癌症治疗中的应用。
    公开号:
    WO2011103546A1
  • 作为产物:
    描述:
    三光气2-甲基-4-溴苯胺四氢呋喃 为溶剂, 反应 3.0h, 以to afford 4-bromo-1-isocyanato-2-methylbenzene 1b (11.4 g, white solid) which的产率得到4-溴-2-甲基异氰酸苯酯
    参考文献:
    名称:
    DGAT1 Inhibitor and Preparation Method and Use Thereof
    摘要:
    本发明揭示了一种新型DGAT1抑制剂,特别是公式(I)或其药学上可接受的盐的化合物,以及其制备和制药组合物,以及它们在制备用于预防和治疗家族性高胆固醇血症(FCS),肥胖症,高脂蛋白血症或高甘油三酯血症的药物中的用途。
    公开号:
    US20160272651A1
点击查看最新优质反应信息

文献信息

  • Use of malonic acid derivative compounds for retarding plant growth
    申请人:Rhone-Poulenc Inc.
    公开号:US05292937A1
    公开(公告)日:1994-03-08
    This invention relates to a method for retarding plant growth by applying to the plant an effective amount of a malonic acid derivative compound. This invention also relates to novel malonic acid derivative compounds and processes for the preparation thereof.
    这项发明涉及一种通过向植物施加丙二酸衍生物化合物的有效量来延缓植物生长的方法。该发明还涉及新颖的丙二酸衍生物化合物及其制备方法。
  • Synergistic plant growth regulator compositions
    申请人:Rhone-Poulenc Nederland B.V.
    公开号:US05123951A1
    公开(公告)日:1992-06-23
    This invention relates to synergistic plant growth regulator compositions containing (1) an ethylene response or ethylene-type response inducing agent and (11) a malonic acid derivative compound. This invention also relates to the use of said compositions for inducing synergistic plant growth regulating responses or ethylene responses or ethylene-type responses.
    这项发明涉及含有(1)乙烯响应或类似乙烯响应诱导剂和(11)丙二酸衍生物化合物的协同植物生长调节剂组合物。该发明还涉及利用上述组合物诱导协同植物生长调节响应或乙烯响应或类似乙烯响应。
  • Highly Diastereoselective Synthesis of Anomeric β-O-Glycopyranosyl Carbamates from Isocyanates
    作者:Ruben G. G. Leenders、Rob Ruytenbeek、Eric W. P. Damen、Hans W. Scheeren
    DOI:10.1055/s-1996-4377
    日期:1996.11
    1-β-O-Glycopyranosyl carbamates are prepared with practically 100% β-diastereoselectivity from anomerically unprotected glycopyranosides and isocyanates. The isocyanates are prepared in situ from carboxylic acids via acyl azides.
    1-β-O-Glycopyranosyl carbamates 是通过在几乎 100% β-对映选择性下,从无保护的α-糖苷和异氰酸酯制备的。异氰酸酯则是由羧酸通过酰基叠氮化物原位制备得来的。
  • Substituted Spiro Compounds and Their Use for Producing Pain-Relief Medicaments
    申请人:Frank Robert
    公开号:US20080269271A1
    公开(公告)日:2008-10-30
    The present invention relates to substituted spiro compounds, to processes for preparing them, to medicaments comprising these compounds and to the use of these compounds for producing medicaments.
    本发明涉及替代螺环化合物,涉及制备这些化合物的方法,涉及含有这些化合物的药物以及利用这些化合物生产药物的用途。
  • Imidazolidine Derivatives, Uses Therefor, Preparation Thereof and Compositions Comprising Such
    申请人:Nique Francois
    公开号:US20100063120A1
    公开(公告)日:2010-03-11
    Compounds of formula (I): wherein X is O or S, R 1 is acyl, aldehyde, cycloalkyl, an optionally substituted alkyl, alkenyl or alkynyl, R 2 is H. alkyl, hydroxyalkyl, haloalkyl, alkenyl, or alkynyl; substituted alkyl; alkylcarbonyl; R 3 and R 4 are H, halogen, alkyl, alkenyl, alkynyl, alkoxyl, alkylthio, hydroxyalkyl, haloalkyl, haloalkenyl, or haloalkynyl; or R 3 and R 4 form an, optionally aromatic or heterocyclic, optionally substituted ring, R 5 is H, halogen, trifluoromethyl, —CN, or —NO2; not all of R 3 , R 4 , and R 5 being H, R 6 and R 9 are H, halogen, OH; alkyl. hydroxyalkyl, alkoxyl, thioalkyl, haloalkyl, alkenyl, or alkynyl; R 7 and R 8 are H, halogen, OH, SH; alkoxyl or alkylthio optionally substituted by OH and/or halogen; one of R 7 and R 8 not being H or halogen; or one of R 7 and R 8 is a pharmaceutically acceptable ester or thioester grouping, or R 6 is C 1-3 -alkyl or, together with either R 1 or R 2 , represents C 1-3 alkylene or alkenylene linking group, optionally substituted by methyl, trifluoromethyl, OH, or halogen, and pharmaceutically acceptable salts and esters thereof, are useful as selective androgen modulators.
    式(I)的化合物:其中X为O或S,R1为酰基,醛基,环烷基,或可选择地取代的烷基,烯基或炔基,R2为H,烷基,羟基烷基,卤代烷基,烯基或炔基;取代烷基;烷基羰基;R3和R4为H,卤素,烷基,烯基,炔基,烷氧基,烷硫基,羟基烷基,卤代烷基,卤代烯基,或卤代炔基;或R3和R4形成一个,可选择的芳香或杂环,可选择地取代的环,R5为H,卤素,三氟甲基,-CN,或-NO2;R3,R4和R5中不全为H,R6和R9为H,卤素,羟基;烷基,羟基烷基,烷氧基,硫代烷基,卤代烷基,烯基,或炔基;R7和R8为H,卤素,羟基,硫氢基;烷氧基或烷硫基,可选择地由羟基和/或卤素取代;R7和R8中的一个不为H或卤素;或R7和R8中的一个为药用可接受的酯或硫酯基团,或R6为C1-3-烷基或,与R1或R2中的任一者一起,代表C1-3烷基或烯基链连接基,可选择地由甲基,三氟甲基,羟基,或卤素取代,以及其药用可接受的盐和酯,可用作选择性雄激素调节剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐